Addiction Treatment Support in Los Angeles
Ketamine Clinics Los Angeles (KCLA) provides outpatient psychiatric support for adults affected by substance use and co-occurring mental health conditions. We help medically stable adults review psychiatric medication, address depression or anxiety, and coordinate care with an addiction-focused clinician or recovery program.
Medication, behavioral treatment, and recovery support are established parts of substance use disorder care. KCLA provides selected outpatient treatment and coordination. We do not provide detox, residential rehabilitation, intensive outpatient programs, or 24-hour addiction care.1
Your free phone consultation is with a care coordinator about appointments, fit, and payment. It is not medical triage, withdrawal management, or a clinical evaluation.
Adults 18+
Los Angeles Appointments
California Telehealth Psychiatry
Is KCLA a good fit for your recovery needs?
A consultation may help if you are medically stable, have depression, anxiety, PTSD, or another psychiatric concern alongside substance use, and want ongoing outpatient care. KCLA can also discuss whether a selected interventional treatment fits an existing recovery plan.
Withdrawal risk, intoxication, overdose risk, and ability to stay safe determine the appropriate level of care. Do not delay urgent addiction treatment while waiting for a KCLA appointment. Call 911 for suspected overdose or severe withdrawal. Give naloxone if opioid overdose is suspected and it is available. Alcohol and benzodiazepine withdrawal can be life-threatening; seek medical guidance before stopping abruptly.
Compare addiction care and related treatment options
The appropriate plan depends on the substance, health risks, and level of care. These services are not interchangeable.
| Option | Role in Addiction care | Main consideration |
|---|---|---|
| Medication | Established treatment for some substance use disorders and co-occurring psychiatric conditions. | KCLA offers psychiatric medication management; confirm addiction-specific prescribing availability. |
| IV Ketamine | A selective adjunct to a broader recovery plan. | Off-label for addiction; evidence is limited and does not establish a general treatment for every substance. |
| TMS | A separate qualifying condition such as depression or OCD. | KCLA's MagVenture clearances do not establish a general addiction indication. |
| Spravato | A separate qualifying adult depression diagnosis. | Not approved for addiction; misuse risk requires assessment. |
| Therapy | Behavioral treatment, relapse prevention, and recovery support. | An addiction-focused clinician or program may be needed outside KCLA. |
Treatment and coordinated support at KCLA
Psychiatric evaluation and medication management
An evaluation reviews substance use, withdrawal or overdose risk, co-occurring symptoms, medications, prior treatment, and the appropriate level of care. Established medications exist for opioid, alcohol, and tobacco use disorders. Methadone treatment for opioid use disorder is generally provided through a certified opioid treatment program.1 KCLA provides psychiatric medication management within its current scope. Confirm direct availability of addiction-specific medications before scheduling; a referral may be appropriate. Do not stop buprenorphine, methadone, or another prescribed treatment without clinical guidance.
IV ketamine for addiction
IV ketamine is not FDA-approved for addiction. Early trials, including research in alcohol use disorder, opioid use disorder, and cocaine use disorder, show strong potential for benefit in selected settings. Results for one substance or study protocol should not be generalized to all addictions. Ketamine is not detox or a substitute for established addiction treatment.2 KCLA typically requires at least 30 days of sobriety and participation in a substance use disorder program before ketamine treatment. This is a KCLA intake policy, not a reason to delay evidence-based addiction medication or withdrawal care. Your clinician determines how the policy applies to prescribed medications and your situation. Risks include dissociation, sedation, blood-pressure changes, and misuse. Screening, monitoring, recovery support, and a ride home are required.
TMS for addiction
KCLA does not offer MagVenture TMS as an FDA-cleared general addiction treatment. It may be appropriate for separately qualifying depression or OCD. Treatment requires repeated clinic visits. Eligibility and coverage follow the condition being treated. [3] Learn about TMS therapy.
Spravato for addiction
Spravato is approved for specific adult depression indications, not addiction. A substance use history requires careful assessment of abuse and misuse risk. Treatment requires a REMS-certified setting and at least two hours of monitoring. Do not drive until the next day after restful sleep.4 Confirm current availability and start dates.
Behavioral treatment and recovery coordination
Treatment may include CBT, motivational approaches, contingency management, relapse prevention, family support, or peer services, depending on the substance and setting. KCLA may provide supportive psychotherapy within psychiatric care and coordinate with an addiction-focused clinician or program with your permission. The intensity of support should match your needs.1
When recovery is not progressing
Continued or renewed substance use calls for reassessment of overdose and withdrawal risk, medication and behavioral treatment, mental health, practical barriers, and the recovery environment. A more structured program may be needed. Returning to use does not mean further treatment cannot help.
Insurance Accepted & Payment Options
KCLA accepts most major insurance plans, including Medicare, for TMS, Spravato, and Psychiatric Care. Some plans may also cover IV Ketamine. Coverage varies by plan, provider, and treatment. Our team can verify your benefits and explain estimated out-of-pocket costs before you begin.
Self-pay financing options include up to 24 months interest-free, subject to eligibility and financing terms.
Understanding substance use disorders
A substance use disorder involves impaired control and continued use despite meaningful harm. Addiction commonly refers to its more severe forms. Alcohol, opioids, stimulants, cannabis, sedatives, and nicotine can each be involved. Genetic, environmental, psychological, and social factors can contribute. 1
Signs may include craving, unsuccessful attempts to cut down, missed responsibilities, risky use, and continued use despite consequences. Tolerance or withdrawal during appropriate prescribed treatment does not by itself establish addiction.
Depression, anxiety, PTSD, ADHD, bipolar disorder, sleep problems, and chronic pain may coexist. This is often called a co-occurring disorder or dual diagnosis. Evaluation considers the pattern and timing of use, its impact, medical risks, and whether symptoms occur during intoxication, withdrawal, or periods without use. A full plan may require both psychiatric and addiction-specialist care.
What to expect at KCLA
1.
Discuss outpatient fit
A coordinator reviews appointment options and payment questions. Urgent medical concerns require immediate clinical care elsewhere.
2.
Complete an evaluation
Review use history, health risks, medications, psychiatric symptoms, recovery supports, and goals.
3.
Review the recommended level of care
Discuss KCLA services, outside treatment, monitoring, and estimated costs.
4.
Coordinate follow-up
Track functioning and symptoms and work with your recovery team when authorized.
Why choose KCLA for addiction-related psychiatric care
KCLA has served Los Angeles since 2014. The team can assess psychiatric needs alongside recovery and coordinate selected treatments with outside providers. Recommendations consider medical stability, existing addiction care, and whether outpatient treatment is appropriate.
Your KCLA Providers
Kathleen Lopez, MD
Psychiatrist, Double Board Certified in Adult Psychiatry and Child and Adolescent Psychiatry
Kathleen Lopez, MD
Kathleen Lopez, MD, is a board-certified psychiatrist specializing in adult psychiatry as well as child and adolescent psychiatry at Ketamine Clinics Los Angeles. She earned her Bachelor of Science in Psychology with a pre-medical focus from Pacific Union College and her medical degree from Loma Linda University School of Medicine. She completed her adult psychiatry residency at the University of California, Riverside, and a child and adolescent psychiatry fellowship at UCLA, where she also served as Administrative Chief.
Dr. Lopez is deeply passionate about expanding access to high-quality mental health care, with a special focus on neurodiverse youth and adults. Fluent in both English and Spanish, she is committed to providing inclusive, compassionate care that supports individuals and families in meaningful and culturally responsive ways.
She was drawn to Ketamine Clinics Los Angeles for its collaborative culture and shared commitment to patient-centered care. Outside the clinic, Dr. Lopez enjoys crocheting, weight lifting, camping, and growing her home library. She also has a background in vocal music and continues to hold a lifelong love for music.
Pascal Stirnimann, DNP, PMHNP-BC
Doctor of Nursing Practice, Psychiatric Mental Health Nurse Practitioner, Board Certified
Pascal Stirnimann, DNP, PMHNP-BC
Pascal Strinimann is a Psychiatric Mental Health Nurse Practitioner at Ketamine Clinics Los Angeles with a Bachelor of Arts in Psychology from the University of Miami and both a Master of Science in Nursing and Doctor of Nursing Practice from Columbia University. He specializes in treating mood disorders, trauma-related disorders, and impulse control disorders across the lifespan.
Pascal has experience in both inpatient and outpatient mental health settings, including training at a women’s shelter in New York City. His clinical background supports a comprehensive and compassionate approach to psychiatric evaluation and treatment.
He takes a holistic, family-informed approach and works closely with clients through shared decision-making to develop personalized treatment plans that support emotional health, functional improvement, and long-term wellness. Outside the clinic, Pascal enjoys spending time outdoors biking, running, or hiking, or indoors cooking and catching up on movies and TV.
Appointments and payment
Visit KCLA at 6801 Park Terrace, Suite 525, Los Angeles, CA 90045, in Playa District. Patient care hours are Monday through Thursday, 9 a.m. to 7 p.m. Pacific. Psychiatry may be available by telehealth while you are physically in California; IV ketamine, TMS, and Spravato require clinic visits.
KCLA accepts most health insurance, which usually covers psychiatry, depending on the plan, clinician, and service. TMS or Spravato generally requires a separate qualifying diagnosis and authorization. IV ketamine for anxiety is commonly self-pay. Benefits checks and estimates do not guarantee payment.
Self-pay psychiatry is $400 for a 60-minute evaluation and $200 for a 30-minute follow-up.
Frequently asked questions
No. KCLA provides selected outpatient psychiatric and interventional care. Detox, residential rehabilitation, intensive programs, and 24-hour support require another setting.
KCLA can evaluate co-occurring psychiatric symptoms when outpatient care is appropriate. A complete plan may also require addiction-specific medication, therapy, or a structured recovery program outside KCLA.
Confirm current prescribing availability during intake. KCLA may manage appropriate medications within its scope or recommend an addiction-focused clinician or program. Do not assume all addiction medications are available here.
No. At KCLA, we consider it only selectively within a broader plan. Evidence for addiction remains limited, and established medication, behavioral treatment, and recovery support remain important.1,2
Find the appropriate next step
If you are medically stable and want psychiatric support during recovery, talk with our team about whether KCLA fits your needs.
Urgent help: KCLA is not an emergency service. Call 911 for immediate danger or a medical emergency. For suicidal or emotional crisis support in the United States, call or text 988. This page is educational; diagnosis, eligibility, and treatment require individual clinical evaluation. Results vary.

